Navigation Links
BCC Research Publishes a New Report on Global Markets for Microbial Products
Date:9/7/2013

Wellesley, MA (PRWEB) September 07, 2013

According to a new technical market research report, Microbial Products: Technologies, Applications and Global Markets from BCC Research (http://www.bccresearch.com), the global market for microbial products was valued at $117 billion in 2012 and is expected to grow to nearly $134 billion in 2013. BCC Research projects the market to reach nearly $179 billion by 2018, and register a compound annual growth rate (CAGR) of 6%.

Microbes were used for centuries to produce bread, wine, vinegar, and other common products —without anyone knowing the scientific basis for the ingredient. The discipline known today as microbiology was not established until the late 19th century.

The technology related to microbial production of metabolites such as ethanol, lactic acid, butanol, and riboflavin, and enzymes such as protease, amylase, and invertase was developed as early as the first few decades of the 20th century. Large-scale production of the antibiotic penicillin from Penicillium fungi was perfected during World War II and the microbial production of other antibiotics, amino acids, nucleotides, and enzymes soon followed.

Today, genetically engineered microbes are used for the commercial production of nonmicrobial products such as insulin, interferon, human growth hormone and viral vaccines. Microbes are also used to produce energy (e.g., biodiesel and bioethanol) and to clean up environmental pollutants such as sewage and oil spills. As the active ingredient in biofertilizers and biopesticides, microbes contribute to increasing agricultural productivity, and form the basis of cost-effective methods of mining and metallurgy. Indeed, the commercial possibilities of microbes appear endless.

This report is an update of an earlier BCC Research report published in 2011. It surveys microbial applications in a wide range of fields based on the most recent data, identifies the applications that appear to have significant commercial potential in the near- to mid-term and to develop quantitative estimates of their current and future sales. This new report from BCC Research analyzes the global market for microbes and microbial products used in commercial applications during the period from 2012 through 2018. These applications include agricultural, healthcare, manufacturing, energy and environmental applications.

This report is intended especially for biotechnology marketing executives, entrepreneurs, investors, venture capitalists and other readers with a need to know where the market for microbial technologies and products is headed over the next five years. Scientists and technologists will also find this study of interest as its findings concern the market for their work, and by extension the availability of government and corporate research funding for different technologies and applications.

Both primary and secondary research methodologies were used in preparing this study. The findings and conclusions of this report are based on information gathered from developers, vendors, and users of microbial products for commercial applications. Interview data was combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and online databases to produce the baseline market estimates contained in this report.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11093968.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: